One-year, mentored award supporting early-career physician-investigators conducting preclinical, clinical, epidemiologic, outcomes, behavioral, quality-of-care, or health-services research with a focus on chronic lymphocytic leukemia (CLL). Designed to fund the transition from fellowship/training to a faculty appointment.
Eligibility Criteria:
-
Physician (MD, DO, or international equivalent); MD/PhD eligible if both degrees are complete before the start date.
-
In the last two years of final oncology subspecialty training at application (limited exceptions possible, including recent graduates within three months of the deadline or programs with research time outside the final two years).
-
Within 10 years of medical degree at submission (exception possible for foreign medical graduates).
-
Planning an investigative career in oncology; valid, active medical license in the country of research; working in an oncology lab or clinical research setting.
-
At least one mentor at the sponsoring institution; ASCO member (or membership application submitted) or sponsor if mentor is not an ASCO member.
-
Able to commit ≥60% total effort to research during the award period.
-
Only one active Conquer Cancer grant at a time; no citizenship or geographic restrictions (visa must allow completion of the project term).
Funding:
-
Total: USD 50,000 for one year, paid in two equal installments; one CLL YIA will be funded in this competition.
-
Budget guidance: at least USD 46,000 to direct research costs; up to USD 1,500 for essential travel (including the Conquer Cancer Grants & Awards Ceremony during the ASCO Annual Meeting); up to USD 2,500 (5%) indirect costs; salary subject to NIH limits.
Deadline:
-
Online applications open: July 1, 2025
-
Full applications due: March 12, 2026 (11:59 PM ET)
-
Notifications: April 2026
-
Award term: July 1, 2026 – June 30, 2027
Where to Go for Further Information:
-
Questions: [email protected]